{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "01/20/2026",
      "update_type": "New",
      "initial_posting_date": "01/20/2026",
      "package_ndc": "25357-025-03",
      "generic_name": "Riboflavin 5-phosphate  Ophthalmic Solution",
      "contact_info": "949-367-9600",
      "related_info": "Discontinuing manufacture of the product as of July 2026.",
      "openfda": {
        "application_number": [
          "NDA203324"
        ],
        "brand_name": [
          "PHOTREXA CROSS-LINKING KIT"
        ],
        "generic_name": [
          "RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC"
        ],
        "manufacturer_name": [
          "Glaukos Corporation"
        ],
        "product_ndc": [
          "25357-025"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "1925825",
          "1925830"
        ],
        "spl_id": [
          "c945d9a7-2e14-41c7-a209-e537aba21749"
        ],
        "spl_set_id": [
          "f82cfe92-1a24-11e3-8ffd-0800200c9a66"
        ],
        "package_ndc": [
          "25357-025-03"
        ]
      },
      "update_date": "01/20/2026",
      "therapeutic_category": [
        "Ophthalmology"
      ],
      "dosage_form": "Ophthalmic Solution",
      "presentation": "Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)",
      "company_name": "Glaukos Corporation",
      "status": "To Be Discontinued"
    }
  ]
}